P. Schoenfeld Asset Management (PSAM)’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-35,000
Closed -$6.2M 83
2020
Q1
$6.2M Buy
+35,000
New +$6.59M 0.67% 27
2019
Q4
Sell
-564,468
Closed -$102M 60
2019
Q3
$95M Buy
564,468
+84,858
+18% +$13.8M 7.64% 2
2019
Q2
$80.3M Buy
479,610
+409,963
+589% +$56.8M 7.04% 6
2019
Q1
$10.2M Buy
+69,647
New +$10.1M 0.8% 27
2018
Q4
Sell
-158,757
Closed -$30.2M 43
2018
Q3
$30.2M Buy
158,757
+757
+0.5% +$139K 2.7% 12
2018
Q2
$26.3K Buy
+158,000
New +$25.4M 1.49% 23
2016
Q4
Sell
-100,554
Closed -$20.8M 46
2016
Q3
$23.2M Buy
100,554
+20,152
+25% +$4.92M 1.78% 20
2016
Q2
$18.6M Buy
80,402
+41,857
+109% +$9.65M 1.19% 22
2016
Q1
$10.3M Buy
+38,545
New +$11M 0.72% 35

Other funds holding AGN

P. Schoenfeld Asset Management (PSAM)'s AGN Position: Q2 2020 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 35,000 shares — an estimated $6.2M sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in AGN in Q1 2016 and held it in 9 quarters. The position peaked at $95M in Q3 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 35,000 Allergan plc shares in Q2 2020, an estimated $6.2M.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in Allergan plc in Q1 2016 and held it in 9 quarters.
  • P. Schoenfeld Asset Management (PSAM)'s Allergan plc position peaked at $95M in Q3 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q2 2020, filed 14 Aug 2020.